Home › Products › Gynaecology › Menotas SP 75IU Injection
Menotas SP 75IU Injection
Salt Composition: MENOTROPHIN
- Manufacturer: INTAS PHARMACEUTICALS LTD
- Pack Size: 1 VIAL(s)
- Dosage Form: INJECTION
- Strength: 75IU
- Prescription Required
- Cold Chain
- Prepaid Only. Non-Returnable.
- Storage: Do not store above 25°C Do not freeze keep the injection away from the reach of children and pets.
₹872.00₹1343.00
Inclusive of all taxes
Product Introduction
Menotas SP 75IU Injection contains menotrophin, an ovulation stimulator from the gonadotropin group of medications. It is a highly purified mixture of follicle-stimulating hormone (FSH) and luteinising hormone (LH), natural hormones produced in both males and females that enable the reproductive organs to function normally.
Menotas SP 75IU Injection is used to treat infertility in women who are not ovulating, including those with polycystic ovarian disease, and who have not responded to treatment with clomiphene citrate. It is also used to stimulate multiple follicles and promote fertility in women undergoing IVF (in-vitro fertilisation) or other assisted conception procedures. The injection is also indicated for treating infertility in men due to low sperm count.
Do not take Menotas SP 75IU Injection if you are allergic to menotrophin or any other ingredient in this medicine. Do not use this medication if you have a tumour in the pituitary gland (a gland at the base of the brain that produces certain hormones, including growth hormones), hypothalamus (an area beneath the thalamus that controls body temperature and blood pressure), uterus, ovaries, breast, testicles, or prostate gland.
Before starting treatment, you will be assessed for underactive thyroid problems, hormone levels, and tumours of the pituitary and hypothalamus. Do not take this medicine if you have ovarian cysts unrelated to PCOD, vaginal bleeding, early menopause, physical problems in the reproductive organs, a removed womb, or if you are pregnant or breastfeeding.
Inform your physician immediately if you experience abdominal pain and swelling, weight gain, diarrhoea, difficulty in breathing, or decreased urination. Inform your physician if you have or have had liver problems or a history of blood clotting disease before beginning treatment.
Uses
Infertility in men and women
How it works
In the absence of sufficient endogenous luteinising hormone (LH), menotrophin binds to the follicle-stimulating hormone receptor (FSH), resulting in ovulation. It also attaches to the LH receptor, causing appropriate hormone release and treating infertility in women and men.
How to Use
It will be given to you by a doctor or nurse in a hospital or clinic setting. It is given as an intramuscular injection (into your muscles) or under the skin. Do not self-administer the injection. Your doctor will decide the dose, route of administration and duration of the treatment based on your disease severity, body weight, and other factors.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Common side effects of Menotas SP 75IU Injection are: Abdominal pain or swelling Headache Nausea Pelvic pain Overstimulation of ovaries Pain or inflammation at the injection site Mood swings Serious side effects of Menotas SP 75IU Injection are: Severe allergic reactions (hypersensitivity reactions)
Expert Tips
If you have missed any dosing appointments, inform your doctor and schedule immediately. This medicine can increase your risk of ectopic pregnancy (pregnancy outside of the womb) if you have a history of fallopian tube disease, miscarriage, multiple pregnancies (twins and triplets), and birth defects in the baby. Your doctor will regularly perform ultrasound scans and blood tests to monitor your response to the treatment.
References
- Goodman & Gilmanâs, The Pharmacological Basis of Therapeutics, Introduction to endocrinology: The hypothalamic-pituitary axis, 12th edition, 2011, 1123.
- KD Tripathi, Essentials of Medical Pharmacology, Anterior pituitary hormonses, 7th edition, 2013, 241.
- Ferring Pharmaceuticals Ltd, Electronic medicines compendium (emc), [Revised on August 2019] [ Accessed on June 2023], https://www.medicines.org.uk/emc/files/pil.1294.pdf
- Ferring Pharmaceuticals, US Food and Drug Administration, [Revised on Feb 2014] [ Accessed on June 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021663s014lbl.pdf
Safety Advice
Pregnancy: unsafe Menotas SP 75IU Injection is unsafe to administer in pregnant women because it may affect the fetus. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant.
Lungs: Consult your doctor It is unknown whether Menotas SP 75IU Injection can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
Breastfeeding: unsafe Breastfeeding is not recommended in patients taking Menotas SP 75IU Injection because the medicine passes into the breast milk in small amounts and may harm your baby.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.